Nayax CCO Moshe Orenstein reports option holdings
Several RSU installments and 500 options are scheduled to vest later, subject to continued service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Nayax Ltd. (NYAX) lists CCO Moshe Orenstein's reported direct holdings as ordinary shares, restricted stock units (RSUs) and stock options. Two option positions each cover 5,000 ordinary shares and expire February 17, 2027. One is fully vested and immediately exercisable; 4,500 of the other are vested, with the remaining 500 vesting December 31, 2026, subject to continued service. The reported exercise price is $38.1074; it is denominated in New Israeli Shekels, with the U.S.-dollar amount reflecting the grant-date exchange rate. Four RSU awards are for 953, 1,049, 1,623 and 10,000 units, with vesting subject to continued service through applicable vesting dates.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Orenstein Moshe
Role
CCO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (Right to Buy) F7, F6 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F9, F8 | -- | -- | -- |
| Holding | Ordinary Shares F1 | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares F2 | -- | -- | -- |
| Holding | Ordinary Shares F3 | -- | -- | -- |
| Holding | Ordinary Shares F4 | -- | -- | -- |
| Holding | Ordinary Shares F5 | -- | -- | -- |
Holdings:
Stock Option (Right to Buy) — 10,000 contracts (Direct);
Ordinary Shares — 20,982 shares (Direct)
Footnotes (9)
- F1. The shares are held on the Tel Aviv Stock Exchange.
- F2. The Reporting Person was granted 953 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 302 RSUs are vested, and the remaining 651 RSUs vest in three equal quarterly installments beginning on December 26, 2026 and ending on June 26, 2027, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
- F3. The Reporting Person was granted 1,049 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 174 RSUs are vested, and the remaining 875 RSUs vest in seven equal quarterly installments beginning on December 25, 2026 and ending on June 25, 2028, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
- F4. The Reporting Person was granted 1,623 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 355 RSUs are vested, and the remaining 1,268 RSUs vest in eleven equal quarterly installments beginning on December 3, 2026 and ending on June 3, 2029, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
- F5. The Reporting Person was granted 10,000 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 2,000 RSUs vest on March 15, 2027, and the remaining 8,000 RSUs vest in four equal annual installments over the following four years, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
- F6. The Stock Options are Fully vested and immediately exercisable
- F7. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
- F8. The Reporting Person holds 5,000 stock options to purchase ordinary shares of Nayax Ltd. (the "Company"). Of these options, 4,500 are vested and currently exercisable, and the remaining 500 options will vest on December 31, 2026, subject to the Reporting Person's continued service to the Company or its subsidiaries through such date.
- F9. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
Key Figures
Option underlying ordinary shares, fully vested position: 5,000 shares
Option underlying ordinary shares, other position: 5,000 shares
Reported U.S.-dollar exercise price: $38.1074
+4 more
7 metrics
Option underlying ordinary shares, fully vested position
5,000 shares
Fully vested and immediately exercisable; expires February 17, 2027.
Option underlying ordinary shares, other position
5,000 shares
4,500 vested; remaining 500 vest December 31, 2026, subject to continued service; expires February 17, 2027.
Reported U.S.-dollar exercise price
$38.1074
Denominated in New Israeli Shekels; the U.S.-dollar amount reflects the grant-date exchange rate.
RSU award
953 RSUs
302 vested; remaining 651 vest in three equal quarterly installments beginning December 26, 2026, and ending June 26, 2027, subject to continued service.
RSU award
1,049 RSUs
174 vested; remaining 875 vest in seven equal quarterly installments beginning December 25, 2026, and ending June 25, 2028, subject to continued service.
RSU award
1,623 RSUs
355 vested; remaining 1,268 vest in eleven equal quarterly installments beginning December 3, 2026, and ending June 3, 2029, subject to continued service.
RSU award
10,000 RSUs
2,000 vest March 15, 2027; remaining 8,000 vest in four equal annual installments over the following four years, subject to continued service.
Key Terms
restricted stock units, contingent right, vested, immediately exercisable
4 terms
restricted stock units financial
"granted 953 restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"each representing a contingent right to receive one ordinary share"
vested financial
"302 RSUs are vested"
immediately exercisable financial
"Fully vested and immediately exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many NYAX stock options did Moshe Orenstein report?
Moshe Orenstein reported two separate option positions, each covering 5,000 ordinary shares and expiring February 17, 2027. The exercise price is reported as $38.1074 and is denominated in New Israeli Shekels; the U.S.-dollar amount reflects the grant-date exchange rate.
When do Moshe Orenstein's NYAX RSUs vest?
The 953-unit, 1,049-unit and 1,623-unit awards have vesting schedules ending June 26, 2027, June 25, 2028 and June 3, 2029, respectively. For the 10,000-unit award, 2,000 units vest March 15, 2027, and 8,000 vest in four equal annual installments over the following four years. Vesting is subject to continued service through the applicable dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
